FDA Adverse Event Injury Summary report: N

COOLSCULPTING® SYSTEM

MDR report key: 17204348 · Received June 26, 2023

Report

Report Number
3007215625-2023-00936
Event Type
Injury
Date Received
June 26, 2023
Date of Event
June 8, 2023
Report Date
August 11, 2023
Manufacturer
ALLERGAN PLEASANTON
Product Code
OOK
PMA / PMN Number
K160259
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING. ACCORDING TO THE COOLSCULPTING USER MANUAL, UNDER RARE ADVERSE EVENTS, PARADOXICAL ADIPOSE HYPERPLASIA (PH/PAH) IS CHARACTERIZED BY A VISIBLY ENLARGED TISSUE VOLUME WITHIN THE TREATMENT AREA, WHICH MAY DEVELOP TWO TO FIVE MONTHS AFTER TREATMENT. SURGICAL INTERVENTION MAY BE REQUIRED. PAH IS NOT RELATED TO ANY COOLSCULPTING DEVICE FAILURE MODE BUT IT IS INCLUDED IN THE RISK MANAGEMENT FILES OF THE DEVICE BECAUSE IT IS A RISK THAT IS INHERENT TO THE USE CRYOLIPOLYSIS FOR LOCALIZED FAT REDUCTION. A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF AND WHEN ADDITIONAL INFORMATION IS OBTAINED.

Additional Manufacturer Narrative · 0

H11: CORRECTED DATA: SUBSEQUENT TO THE SUBMISSION OF INITIAL MEDWATCH, THIS REPORT HAS BEEN IDENTIFIED AS A DUPLICATE OF PREVIOUSLY SUBMITTED MEDWATCH REPORT OF 3007215625-2023-00933-00.

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT THAT A PATIENT RECEIVED A COOLSCULPTING TREATMENT TO THE DISTAL THIGH ON (B)(6) 2022 USING THE COOLMINI APPLICATOR AND PRESENTED WITH PARADOXICAL HYPERPLASIA (PAH/PH).

Description of Event or Problem · 0

ALLERGAN AESTHETICS RECEIVED A REPORT THAT A PATIENT RECEIVED A COOLSCULPTING TREATMENT TO THE DISTAL THIGH ON (B)(6) 2022 USING THE COOLMINI APPLICATOR AND PRESENTED WITH PARADOXICAL HYPERPLASIA (PAH/PH).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
931478 COOLSCULPTING® SYSTEM DERMADERMAL COOLING PACK/VACUUM/MASSAGER OOK ALLERGAN PLEASANTON NI

Patients

Seq Age Sex Outcome Treatment
1 41 YR Female Required Intervention